Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial

<b>Objectives</b>: This phase 3 clinical trial aimed to evaluate the safety and immunogenicity of the Sabin inactivated poliovirus vaccine (sIPV) manufactured by Biominhai in healthy infants following a sequential immunization regimen. <b>Methods</b>: A total of 300 healthy infants aged 2 months wer...

Description complète

Détails bibliographiques

Auteurs principaux:	Yafei Liu, Xiaodong Liu, Li Zhang, Xianyun Chang, Ping Xiong, Yanxin Guan, Yixin Li, Weiling Zhang, Lili Xuan, Yan Li, Zhifang Ying, Qing Xu
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-10-01
Collection:	Vaccines
Sujets:	safety immunogenicity sIPV bOPV sequential immunization
Accès en ligne:	https://www.mdpi.com/2076-393X/13/11/1094
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!